Cite
APA Citation
Cohen, S. B., Pope, J., Haraoui, B., Mysler, E., Diehl, A., Lukic, T., Liu, S., Stockert, L., Germino, R., Menon, S., Shi, H., & Keystone, E. C. (2021). efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift). RMD open, 7(2), . http://access.bl.uk/ark:/81055/vdc_100132247234.0x000004